Harrison’s blood contained a rare antibody known as Anti-D, which can be used to make medication to give to pregnant women with rhesus disease. Rhesus disease isn’t harmful to the mother ...

Harrison’s blood has unique, disease-fighting antibodies that have been used to develop an injection called Anti-D, which helps fight against rhesus disease. This disease is a condition where a ...

If the baby’s blood enters the mother’s bloodstream during pregnancy or birth; the mother produces antibodies known as anti-D antibodies against the rhesus positive cells in the baby’s blood.

For Rhesus D negative women with Rhesus D positive fetuses, half of all sensitizations occur in the first pregnancy, with most women developing anti-D antibodies during the second or third ...

Harrison’s rare antibodies were crucial in developing Anti-D, the treatment that has protected millions of newborns from Rhesus disease (or Haemolytic Disease of the Foetus and Newborn ...

If the baby has a negative blood group like the mother, then anti-D is NOT needed. The injection protects the mother’s future Rhesus positive babies from the effect of sensitisation of the mom ...

Standard prophylaxis for all rhesus-negative pregnant women All Rh-negative pregnant women in Germany currently receive a standard dose of anti-D immunoglobulin. These antibodies are used to ...

For more information, see the review decision. The guidance on TA156 updates NICE technology appraisal guidance on the clinical effectiveness and cost effectiveness of routine anti-D prophylaxis for ...

TA156; Routine antenatal anti-D prophylaxis for women who are rhesus D negative was added to the static list in August 2011. In 2014, the Institute received a request to re-consider this appraisal ...